TARS
Tarsus Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $3.37B
- Employees
- 370
- Latest publication
- 2026-09-29
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20222022-12-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD | Q1 20222022-03-31 · USD | Q4 20212021-12-31 · USD | Q3 20212021-09-30 · USD | Q2 20212021-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 173,912,000USD | 10,000,000USD | 0USD | 15,277,000USD | 539,000USD | 338,000USD | 1,240,000USD | 22,017,000USD |
| Cost Of Revenue | 12,113,000USD | 400,000USD | 211,000USD | 522,000USD | 33,000USD | -24,000USD | 65,000USD | 737,000USD |
| Gross Profit | 161,799,000USD | 9,600,000USD | -211,000USD | 14,755,000USD | 506,000USD | 362,000USD | 1,175,000USD | 21,280,000USD |
| Research Development | 31,010,000USD | 10,028,000USD | 10,912,000USD | 9,603,000USD | 12,081,000USD | 8,038,000USD | 10,209,000USD | 7,204,000USD |
| Selling General Administrative | 150,697,000USD | 14,633,000USD | 11,994,000USD | 10,376,000USD | 7,946,000USD | 6,772,000USD | 6,671,000USD | 6,794,000USD |
| Total Operating Expenses | 181,707,000USD | 24,661,000USD | 22,695,000USD | 19,979,000USD | 20,027,000USD | 14,810,000USD | 16,880,000USD | 13,998,000USD |
| Operating Income | -19,908,000USD | -15,061,000USD | -22,906,000USD | -5,224,000USD | -19,521,000USD | -14,448,000USD | -15,705,000USD | 7,282,000USD |
| Total Other Income Expense Net | 4,073,000USD | 1,462,000USD | 390,000USD | -519,000USD | -716,000USD | -349,000USD | -333,000USD | -908,000USD |
| Interest Expense | 2,156,000USD | 692,000USD | 633,000USD | 544,000USD | 316,000USD | 12,000USD | 8,000USD | 7,000USD |
| Income Before Tax | -15,835,000USD | -13,599,000USD | -22,516,000USD | -5,743,000USD | -20,237,000USD | -14,797,000USD | -16,038,000USD | 6,374,000USD |
| Income Tax Expense | 2,716,000USD | -521,000USD | -5,000USD | 519,000USD | 1,000USD | 54,000USD | -341,000USD | 29,000USD |
| Net Income | -18,551,000USD | -13,599,000USD | -22,511,000USD | -5,743,000USD | -20,238,000USD | -14,851,000USD | -15,697,000USD | 6,299,000USD |
| Interest Income | — | 2,127,000USD | 1,061,000USD | — | — | — | — | — |
| Net Interest Income | — | 1,435,000USD | 428,000USD | -247,000USD | -316,000USD | 12,000USD | 8,000USD | 7,000USD |
| Tax Provision | — | 0USD | -5,000USD | 0USD | 1,000USD | 54,000USD | -341,000USD | 29,000USD |
| Net Income From Continuing Ops | — | -13,599,000USD | -22,511,000USD | -5,743,000USD | -20,238,000USD | -14,851,000USD | -15,697,000USD | 6,345,000USD |
| Ebit | — | -12,907,000USD | -21,929,000USD | -5,199,000USD | -19,921,000USD | -14,797,000USD | -16,038,000USD | 6,374,000USD |
| Ebitda | — | -12,809,000USD | -21,835,000USD | -5,107,000USD | -19,880,000USD | -14,757,000USD | -15,955,000USD | 6,543,000USD |
| Depreciation And Amortization | — | 98,000USD | 94,000USD | 92,000USD | 41,000USD | 40,000USD | 83,000USD | 169,000USD |
| Reconciled Depreciation | — | 98,000USD | 94,000USD | 92,000USD | 41,000USD | 40,000USD | 83,000USD | 169,000USD |
| Non Operating Income Net Other | — | -1,034,000USD | 1,023,000USD | -272,000USD | -400,000USD | -361,000USD | -341,000USD | -915,000USD |
| Net Income Applicable To Common Shares | — | -13,599,000USD | -22,511,000USD | -5,743,000USD | -20,238,000USD | -14,851,000USD | -15,697,000USD | 6,345,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 25,816,000USD | 33,432,000USD | 0USD | 0USD |
| Cost Of Revenue | 955,000USD | 246,000USD | 74,000USD | 1,000USD |
| Gross Profit | 24,861,000USD | -246,000USD | -74,000USD | -1,000USD |
| Research Development | 42,624,000USD | 18,826,000USD | 3,162,000USD | 901,000USD |
| Selling General Administrative | 44,949,000USD | 8,172,000USD | 1,136,000USD | 449,000USD |
| Total Operating Expenses | 87,573,000USD | 26,737,000USD | 4,224,000USD | 1,349,000USD |
| Operating Income | -62,712,000USD | -26,983,000USD | -4,298,000USD | -1,350,000USD |
| Interest Income | 3,499,000USD | 188,000USD | — | — |
| Interest Expense | 2,064,000USD | 188,000USD | 40,000USD | 0USD |
| Net Interest Income | 1,300,000USD | 188,000USD | -40,000USD | 32,000USD |
| Income Before Tax | -62,095,000USD | -26,810,000USD | -4,669,000USD | -1,318,000USD |
| Income Tax Expense | -4,000USD | 1,000USD | 1,000USD | 1,000USD |
| Tax Provision | -4,000USD | 1,000USD | 1,000USD | 1,000USD |
| Net Income | -62,091,000USD | -26,811,000USD | -4,670,000USD | -1,319,000USD |
| Net Income From Continuing Ops | -62,091,000USD | -26,811,000USD | -4,670,000USD | -1,319,000USD |
| Ebit | -60,031,000USD | -26,810,000USD | -4,629,000USD | -1,318,000USD |
| Ebitda | -59,705,000USD | -26,564,000USD | -4,555,000USD | -1,317,000USD |
| Depreciation And Amortization | 326,000USD | 246,000USD | 74,000USD | 1,000USD |
| Reconciled Depreciation | 325,000USD | 246,000USD | 74,000USD | 1,000USD |
| Total Other Income Expense Net | 617,000USD | 173,000USD | -371,000USD | 32,000USD |
| Non Operating Income Net Other | -683,000USD | — | — | — |
| Net Income Applicable To Common Shares | -62,091,000USD | -26,811,000USD | -4,670,000USD | -1,319,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 611,142,000USD | 581,135,000USD | 562,158,000USD | 534,561,000USD | 494,994,000USD | 500,750,000USD | 376,991,000USD | 376,300,000USD |
| Short Term Investments | 245,095,000USD | 286,540,000USD | 233,627,000USD | 289,113,000USD | 284,495,000USD | 232,129,000USD | 196,557,000USD | 140,742,000USD |
| Long Term Investments | 6,682,000USD | 3,870,000USD | 3,870,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Total Current Assets | 561,989,000USD | 537,229,000USD | 522,782,000USD | 501,704,000USD | 474,429,000USD | 480,773,000USD | 356,705,000USD | 357,117,000USD |
| Other Non Current Assets | 660,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 264,410,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 175,753,000USD | 143,508,000USD | 135,695,000USD | 117,050,000USD | 90,253,000USD | 86,308,000USD | 80,612,000USD | 65,868,000USD |
| Other Non Current Liabilities | 15,895,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 346,732,000USD | 348,951,000USD | 343,426,000USD | 335,082,000USD | 332,612,000USD | 342,458,000USD | 224,534,000USD | 237,484,000USD |
| Total Equity Including Noncontrolling Interest | 346,732,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 72,762,000USD | 72,597,000USD | 72,438,000USD | 72,281,000USD | 72,129,000USD | 71,984,000USD | 71,845,000USD | 71,708,000USD |
| Net Receivables | 96,028,000USD | 117,207,000USD | 87,109,000USD | 74,336,000USD | 60,240,000USD | 64,153,000USD | 48,059,000USD | 30,304,000USD |
| Inventory | 4,377,000USD | 4,572,000USD | 4,372,000USD | 3,836,000USD | 3,873,000USD | 2,705,000USD | 2,620,000USD | 2,846,000USD |
| Property Plant Equipment Net | 30,400,000USD | 27,666,000USD | 21,745,000USD | 15,979,000USD | 3,411,000USD | 3,180,000USD | 2,866,000USD | 4,195,000USD |
| Intangible Assets | 6,885,000USD | 7,126,000USD | 7,366,000USD | 7,606,000USD | 7,846,000USD | 8,086,000USD | 8,326,000USD | 8,567,000USD |
| Accounts Payable | 40,141,000USD | 24,131,000USD | 16,387,000USD | 40,642,000USD | 28,075,000USD | 28,383,000USD | 27,739,000USD | 26,815,000USD |
| Common Stock | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -452,146,000USD | -433,595,000USD | -426,628,000USD | -418,255,000USD | -405,670,000USD | -385,330,000USD | -360,210,000USD | -337,097,000USD |
| Accumulated Other Comprehensive Income | -557,000USD | -298,000USD | 381,000USD | 289,000USD | 39,000USD | 85,000USD | 179,000USD | 346,000USD |
| Other Current Assets | — | 26,718,000USD | 14,033,000USD | 21,695,000USD | 29,173,000USD | 5,999,000USD | 14,650,000USD | 7,015,000USD |
| Total Liab | — | 232,184,000USD | 218,732,000USD | 199,479,000USD | 162,382,000USD | 158,292,000USD | 152,457,000USD | 138,816,000USD |
| Other Current Liab | — | 119,377,000USD | 119,308,000USD | 76,328,000USD | 61,861,000USD | 57,541,000USD | 52,265,000USD | 38,422,000USD |
| Capital Stock | — | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Cash | — | 102,192,000USD | 183,641,000USD | 112,724,000USD | 96,648,000USD | 175,787,000USD | 94,819,000USD | 176,210,000USD |
| Cash And Short Term Investments | — | 388,732,000USD | 417,268,000USD | 401,837,000USD | 381,143,000USD | 407,916,000USD | 291,376,000USD | 316,952,000USD |
| Net Debt | — | -13,516,000USD | -90,005,000USD | -30,215,000USD | -24,202,000USD | -103,419,000USD | -22,366,000USD | -103,871,000USD |
| Short Long Term Debt Total | — | 88,676,000USD | 93,636,000USD | 82,509,000USD | 72,446,000USD | 72,368,000USD | 72,453,000USD | 72,339,000USD |
| Property Plant Equipment Gross | — | 29,961,000USD | 23,843,000USD | 18,608,000USD | 5,820,000USD | 5,376,000USD | 4,842,000USD | 5,978,000USD |
| Common Stock Shares Outstanding | — | 42,956,973shares | 42,784,688shares | 42,607,717shares | 42,360,452shares | 39,345,359shares | 38,560,907shares | 38,381,968shares |
| Non Current Assets Total | — | 43,905,999USD | 39,376,000USD | 32,857,000USD | 20,565,000USD | 19,977,000USD | 20,286,000USD | 19,183,000USD |
| Non Current Liabilities Total | — | 88,675,999USD | 83,037,000USD | 82,429,000USD | 72,129,000USD | 71,984,000USD | 71,845,000USD | 72,948,000USD |
| Non Current Liabilities Other | — | 16,079,000USD | 10,599,000USD | 10,148,000USD | — | — | — | 1,240,000USD |
| Non Currrent Assets Other | — | 3,242,999USD | 6,395,000USD | 3,709,000USD | 6,308,000USD | 5,711,000USD | 6,094,000USD | 3,421,000USD |
| Net Working Capital | — | 393,721,000USD | 387,087,000USD | 384,654,000USD | 384,176,000USD | 394,465,000USD | 276,093,000USD | 291,249,000USD |
| Unclassified Non Current Assets | — | 2,001,000USD | — | 2,563,000USD | — | — | — | — |
| Unclassified Equity | — | 782,832,000USD | 769,661,000USD | 753,036,000USD | 738,231,000USD | 727,691,000USD | 584,553,000USD | 574,223,000USD |
| Short Term Debt | — | — | — | 80,000USD | 317,000USD | 384,000USD | 608,000USD | 631,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 562,158,000USD | 376,991,000USD | 265,491,000USD | 227,863,000USD | 178,907,000USD | 171,972,000USD | 58,316,000USD | 2,389,000USD |
| Intangible Assets | 7,366,000USD | 8,326,000USD | 3,867,000USD | — | — | — | — | — |
| Other Current Assets | 14,033,000USD | 14,650,000USD | 7,868,000USD | 4,767,000USD | 4,045,000USD | 2,506,000USD | 42,000USD | 24,000USD |
| Total Liab | 218,732,000USD | 152,457,000USD | 68,503,000USD | 34,963,000USD | 12,177,000USD | 5,992,000USD | 64,321,000USD | 3,743,000USD |
| Total Stockholder Equity | 343,426,000USD | 224,534,000USD | 196,988,000USD | 192,900,000USD | 166,730,000USD | 165,980,000USD | -6,005,000USD | -1,354,000USD |
| Other Current Liab | 119,308,000USD | 52,265,000USD | 18,766,000USD | 9,196,000USD | 7,261,000USD | 2,868,000USD | 299,000USD | 4,000USD |
| Common Stock | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 2,000USD | 1,000USD |
| Capital Stock | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 2,000USD | 1,000USD |
| Retained Earnings | -426,628,000USD | -360,210,000USD | -244,656,000USD | -108,763,000USD | -46,672,000USD | -32,845,000USD | -6,034,000USD | -1,364,000USD |
| Cash | 183,641,000USD | 94,819,000USD | 224,947,000USD | 71,660,000USD | 171,332,000USD | 168,129,000USD | 57,952,000USD | 2,355,000USD |
| Cash And Short Term Investments | 417,268,000USD | 291,376,000USD | 227,442,000USD | 217,026,000USD | 171,815,000USD | 168,129,000USD | 57,952,000USD | 2,355,000USD |
| Total Current Assets | 522,782,000USD | 356,705,000USD | 256,131,000USD | 225,375,000USD | 175,952,000USD | 170,655,000USD | 58,030,000USD | 2,383,000USD |
| Total Current Liabilities | 135,695,000USD | 80,612,000USD | 36,936,000USD | 15,429,000USD | 11,478,000USD | 5,387,000USD | 819,000USD | 179,000USD |
| Net Debt | -90,005,000USD | -22,366,000USD | -194,730,000USD | -51,453,000USD | -169,441,000USD | -167,298,000USD | -57,788,000USD | -2,355,000USD |
| Short Long Term Debt Total | 93,636,000USD | 72,453,000USD | 30,217,000USD | 20,207,000USD | 1,891,000USD | 831,000USD | 164,000USD | — |
| Long Term Debt | 72,438,000USD | 71,845,000USD | 29,819,000USD | 19,434,000USD | — | — | — | — |
| Long Term Investments | 3,870,000USD | 3,000,000USD | 631,000USD | 371,000USD | 0USD | — | — | — |
| Short Term Investments | 233,627,000USD | 196,557,000USD | 2,495,000USD | 145,366,000USD | 483,000USD | 0USD | — | — |
| Net Receivables | 87,109,000USD | 48,059,000USD | 17,714,000USD | 3,582,000USD | 92,000USD | 20,000USD | 36,000USD | 4,000USD |
| Inventory | 4,372,000USD | 2,620,000USD | 3,107,000USD | 4,762,233USD | 175,684,140USD | — | 20,000USD | — |
| Accounts Payable | 16,387,000USD | 27,739,000USD | 17,772,000USD | 5,498,000USD | 2,856,000USD | 2,237,000USD | 456,000USD | 175,000USD |
| Property Plant Equipment Net | 21,745,000USD | 2,866,000USD | 3,348,000USD | 1,532,000USD | 1,829,000USD | 1,236,000USD | 280,000USD | 6,000USD |
| Property Plant Equipment Gross | 23,843,000USD | 4,842,000USD | 4,638,000USD | 957,000USD | 1,829,000USD | 548,000USD | 280,000USD | 6,000USD |
| Accumulated Other Comprehensive Income | 381,000USD | 179,000USD | -2,000USD | -74,000USD | — | -171,972,000USD | -63,402,000USD | -1,000USD |
| Common Stock Shares Outstanding | 41,784,014shares | 37,604,538shares | 29,383,276shares | 24,619,700shares | 20,554,086shares | 20,323,201shares | 19,509,014shares | 4,285,262shares |
| Non Current Assets Total | 39,376,000USD | 20,286,000USD | 9,360,000USD | 2,488,000USD | 2,955,000USD | 1,317,000USD | 286,000USD | 6,000USD |
| Non Current Liabilities Total | 83,037,000USD | 71,845,000USD | 31,567,000USD | 19,534,000USD | 699,000USD | 605,000USD | 63,502,000USD | 3,564,000USD |
| Non Current Liabilities Other | 10,599,000USD | — | 1,748,000USD | 100,000USD | 699,000USD | 605,000USD | — | — |
| Non Currrent Assets Other | 6,395,000USD | 6,094,000USD | 1,514,000USD | 585,000USD | 463,000USD | 81,000USD | 6,000USD | — |
| Net Working Capital | 387,087,000USD | 276,093,000USD | 219,195,000USD | 209,946,000USD | 164,474,000USD | 165,268,000USD | 57,211,000USD | 2,204,000USD |
| Unclassified Equity | 769,661,000USD | 584,553,000USD | 441,636,000USD | 301,727,000USD | 213,394,000USD | 370,789,000USD | 63,427,000USD | — |
| Short Term Debt | — | 608,000USD | 398,000USD | 721,000USD | 1,306,000USD | 282,000USD | 64,000USD | — |
| Other Assets | — | — | 1USD | 477,000USD | 178,907USD | 769,000USD | 6,000USD | — |
| Other Liab | — | — | — | 48,000USD | 114,000USD | 56,000USD | — | — |
| Net Tangible Assets | — | — | — | 192,900,000USD | 166,730,000USD | 165,980,000USD | -6,005,000USD | -1,354,000USD |
| Unclassified Current Assets | — | — | — | -4,762,233USD | -175,684,140USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | 697,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 63,502,000USD | 3,564,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6,967,000USD | -8,373,000USD | -12,585,000USD | -20,340,000USD | -25,120,000USD | -23,113,000USD | -23,420,000USD | -33,290,000USD |
| Depreciation | 437,000USD | 443,000USD | 400,000USD | 453,000USD | 460,000USD | 432,000USD | 284,000USD | 239,000USD |
| Stock Based Compensation | 11,967,000USD | 14,314,000USD | 12,243,000USD | 8,233,000USD | 6,930,000USD | 7,403,000USD | 7,415,000USD | 7,481,000USD |
| Other Non Cash Items | -613,000USD | -629,000USD | -1,129,000USD | -1,378,000USD | -1,011,000USD | -1,177,000USD | 8,732,000USD | 914,000USD |
| Change To Account Receivables | -30,098,000USD | -12,773,000USD | -14,096,000USD | 3,913,000USD | -16,095,000USD | -17,755,000USD | 588,000USD | 521,000USD |
| Change To Inventory | -196,000USD | -536,000USD | 37,000USD | -1,168,000USD | -84,000USD | 227,000USD | -652,000USD | -692,000USD |
| Change In Working Capital | -29,476,000USD | 13,575,000USD | 19,328,000USD | -16,355,000USD | -1,910,000USD | -5,727,000USD | -1,663,000USD | 10,252,000USD |
| Total Cash From Operating Activities | -24,652,000USD | 19,330,000USD | 18,257,000USD | -29,387,000USD | -20,651,000USD | -22,182,000USD | -8,652,000USD | -14,404,000USD |
| Capital Expenditures | -5,818,000USD | -6,358,000USD | -1,910,000USD | -1,001,000USD | -590,000USD | -5,072,000USD | -282,000USD | -1,039,000USD |
| Free Cash Flow | -30,470,000USD | 12,972,000USD | 16,347,000USD | -30,388,000USD | -21,241,000USD | -27,254,000USD | -8,934,000USD | -15,443,000USD |
| Investments | -52,744,000USD | 55,632,000USD | -4,743,000USD | -51,704,000USD | -34,942,000USD | -59,574,000USD | 3,128,000USD | -40,525,000USD |
| Total Cashflows From Investing Activities | -58,562,000USD | 49,274,000USD | -4,743,000USD | -51,704,000USD | -34,942,000USD | -59,574,000USD | 3,128,000USD | -40,525,000USD |
| Total Cash From Financing Activities | 1,204,000USD | 2,312,000USD | 2,562,000USD | 1,952,000USD | 136,562,000USD | 2,927,000USD | 639,000USD | 42,319,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 0USD | -354,000USD | 135,125,000USD | 0USD | -9,408,000USD | -274,000USD |
| Change In Cash | -82,009,000USD | 70,916,000USD | 16,076,000USD | -79,139,000USD | 80,969,000USD | -78,829,000USD | -4,885,000USD | -12,610,000USD |
| Begin Period Cash Flow | 184,201,000USD | 115,287,000USD | 99,211,000USD | 178,350,000USD | 97,381,000USD | 176,210,000USD | 181,095,000USD | 193,705,000USD |
| End Period Cash Flow | 102,192,000USD | 186,203,000USD | 115,287,000USD | 99,211,000USD | 178,350,000USD | 97,381,000USD | 176,210,000USD | 181,095,000USD |
| Other Cashflows From Financing Activities | 1,204,000USD | 2,312,000USD | 2,562,000USD | 2,306,000USD | 1,437,000USD | 31,877,000USD | 682,000USD | -31,877,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | -2,833,000USD | — | — | -5,000,000USD | 3,000,000USD | -3,000,000USD |
| Unclassified Investing Cash Flow | — | — | 4,743,000USD | 1,001,000USD | — | 10,072,000USD | -2,718,000USD | 4,039,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -28,950,000USD | -6,728,000USD | 80,881,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 6,685,000USD | -6,685,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -66,418,000USD | -115,554,000USD | -135,893,000USD | -62,091,000USD | -13,827,000USD | -26,811,000USD | -4,670,000USD | -1,319,000USD |
| Depreciation | 1,816,000USD | 1,225,000USD | 877,000USD | 325,000USD | 312,000USD | 96,000USD | 37,000USD | 1,000USD |
| Stock Based Compensation | 41,720,000USD | 27,818,000USD | 19,830,000USD | 13,460,000USD | 8,455,000USD | 839,000USD | 18,000USD | 9,000USD |
| Other Non Cash Items | -4,207,000USD | -360,000USD | -2,613,000USD | 227,000USD | 7,436,000USD | 3,280,000USD | 457,000USD | -116,000USD |
| Change To Account Receivables | -39,051,000USD | -30,139,000USD | -14,131,000USD | -3,490,000USD | -73,000USD | 16,000USD | -32,000USD | -4,000USD |
| Change To Inventory | -1,751,000USD | -2,046,000USD | -3,107,000USD | 3,490,000USD | 73,000USD | -16,000USD | 32,000USD | — |
| Change In Working Capital | 14,638,000USD | 3,844,000USD | 306,000USD | -951,000USD | 1,372,000USD | 1,458,000USD | 485,000USD | 126,000USD |
| Total Cash From Operating Activities | -12,451,000USD | -83,027,000USD | -117,493,000USD | -49,030,000USD | 3,748,000USD | -21,138,000USD | -3,673,000USD | -1,183,000USD |
| Capital Expenditures | -9,859,000USD | -1,567,000USD | -5,502,000USD | -506,000USD | -586,000USD | -456,000USD | -175,000USD | -7,000USD |
| Free Cash Flow | -22,310,000USD | -84,594,000USD | -122,995,000USD | -49,536,000USD | 3,162,000USD | -21,594,000USD | -3,848,000USD | -1,190,000USD |
| Investments | -32,256,000USD | -199,195,000USD | 35,535,000USD | -144,123,000USD | -586,000USD | -456,000USD | -175,000USD | -7,000USD |
| Total Cashflows From Investing Activities | -42,115,000USD | -199,195,000USD | 140,604,000USD | -144,629,000USD | -586,000USD | -456,000USD | -175,000USD | -7,000USD |
| Net Borrowings | 0USD | 75,000,000USD | 10,000,000USD | -875,000USD | 20,000,000USD | 20,000,000USD | 1,989,000USD | 1,989,000USD |
| Total Cash From Financing Activities | 143,388,000USD | 154,656,000USD | 130,176,000USD | 93,987,000USD | 21,000USD | 131,771,000USD | 59,445,000USD | 3,564,000USD |
| Issuance Of Capital Stock | 134,771,000USD | 98,287,000USD | 99,377,000USD | 74,352,000USD | 91,457,000USD | 131,429,000USD | 57,456,000USD | 3,564,000USD |
| Change In Cash | 88,822,000USD | -127,566,000USD | 153,287,000USD | -99,672,000USD | 3,183,000USD | 110,177,000USD | 55,597,000USD | 2,374,000USD |
| Begin Period Cash Flow | 97,381,000USD | 224,947,000USD | 71,660,000USD | 171,332,000USD | 168,149,000USD | 57,972,000USD | 2,375,000USD | 1,000USD |
| End Period Cash Flow | 186,203,000USD | 97,381,000USD | 224,947,000USD | 71,660,000USD | 171,332,000USD | 168,149,000USD | 57,972,000USD | 2,375,000USD |
| Other Cashflows From Financing Activities | 143,388,000USD | -18,631,000USD | 1,577,000USD | -365,000USD | 21,000USD | 40,098,000USD | 57,456,000USD | 3,564,000USD |
| Unclassified Financing Cash Flow | -134,771,000USD | — | 19,222,000USD | 20,290,000USD | -20,324,000USD | 71,701,000USD | -57,456,000USD | -5,553,000USD |
| Other Cashflows From Investing Activities | — | -5,000,000USD | -4,000,000USD | -144,123,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | 6,567,000USD | 114,571,000USD | 144,123,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | 3,475,000USD | 5,753,000USD | 3,240,000USD | 245,000USD | 131,000USD |
| Sale Purchase Of Stock | — | — | — | 74,937,000USD | 324,000USD | -28,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -99,672,000USD | 3,183,000USD | 110,177,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | License And Collaboration | 0 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 173,912,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | License And Collaboration | 16,667,000 | USD | 0001819790-26-000038 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 145,387,000 | USD | 0001819790-26-000038 |
| Q4 2025Quarterly · 2025-12-31 | Product | License And Collaboration | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 151,668,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | License And Collaboration | 0 | USD | 0001819790-26-000019 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 451,360,000 | USD | 0001819790-26-000019 |
| Q3 2025Quarterly · 2025-09-30 | Product | License And Collaboration | 0 | USD | 0001819790-25-000121 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 118,697,000 | USD | 0001819790-25-000121 |
| Q2 2025Quarterly · 2025-06-30 | Product | License And Collaboration | 0 | USD | 0001819790-25-000108 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 102,660,000 | USD | 0001819790-25-000108 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Collaboration | 0 | USD | 0001819790-26-000038 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 78,335,000 | USD | 0001819790-26-000038 |
| Q4 2024Quarterly · 2024-12-31 | Product | License And Collaboration | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 66,408,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | License And Collaboration | 2,894,000 | USD | 0001819790-26-000019 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 180,059,000 | USD | 0001819790-26-000019 |
| Q3 2024Quarterly · 2024-09-30 | Product | License And Collaboration | 0 | USD | 0001819790-24-000129 |
| Q3 2024Quarterly · 2024-09-30 | Product | License And Collaboration Other | 0 | USD | 0001819790-24-000129 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 48,118,000 | USD | 0001819790-24-000129 |
| FY 2023Yearly · 2023-12-31 | Product | License And Collaboration | 2,718,000 | USD | 0001819790-26-000019 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 14,729,000 | USD | 0001819790-26-000019 |
| FY 2022Yearly · 2022-12-31 | Product | License And Collaboration Other | 0 | USD | 0001819790-24-000018 |
| FY 2022Yearly · 2022-12-31 | Product | License Fees And Collaboration | 25,816,000 | USD | 0001819790-24-000018 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 0 | USD | 0001819790-24-000018 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Revenue | 3,960,000 | USD | 0001819790-23-000007 |
| FY 2021Yearly · 2021-12-31 | Product | License And Service | 53,067,000 | USD | 0001819790-23-000007 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.